Both in Pharmaceuticals
Citius Oncology vs Heron Therapeutics
Over the past year CTOR returned −68.0% and HRTX returned −75.6%; their daily moves had a correlation of 0.08.
CTOR −68.0% HRTX −75.6%Growth of $1, one year, split-adjusted
| Metric | CTOR | HRTX |
|---|---|---|
| Price | $0.5540 | $0.2777 |
| Market cap | $58.6M | $52.7M |
| Today | +4.63% | −5.67% |
| 1 month | −43.5% | −22.0% |
| 6 months | −41.4% | −78.1% |
| Year to date | −44.6% | −78.6% |
| 1 year | −68.3% | −76.3% |
| Revenue growth (YoY) | — | +1.3% |
| Gross margin | 67.1% | 69.3% |
| Net margin | −597.4% | −14.6% |
| P/E (TTM) | — | — |
| Price / sales | 8.2× | 0.3× |
| Net cash | $10.2M | -$100.0M |
| Dividend yield | — | — |
| Volatility (60d) | 96.7% | 115.7% |
| Short % of float | 0.8% | 25.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).